NTAP research initiatives are dedicated to filling critical gaps in the pipeline todeveloping therapies for patients with cutaneous neurofibromas (cNFs) and plexiformneurofibromas (pNF). Informed by discussions with patients, scientists, clinicians,industry leaders, investors and government collaborators, NTAP has identified criticalgaps in knowledge that limit the development of therapeutics for cNFs and pNFs.Research initiatives recruit investigators with innovative ideas to address these gapsas quickly and robustly as technology will allow.

NTAP-directed grants target specific research questions where providing funding orother support can accelerate cNF and pNF drug discovery and remove obstacles toclinical development. In addition, NTAP invites proposals from any investigator(regardless of their location or primary research focus) who have independentresearch projects (open proposals) designed to accelerate the development ofeffective treatments for cNFs and pNFs.

Current NTAP initiatives include:

Biomarker Development